Bulletin references January 2026
You can read the January 2026 Bulletin here.
Pathology solutions
How the Anthony Nolan charity is addressing haematopoietic cell transplant inequities from all angles
- Mayor NP, Szydlo RM, Sheikh Y, Lee J, Pearce RM, Farrow C et al. The impact of patient ethnicity on haematopoietic cell transplantation outcome: a retrospective cohort study on the UK experience. Lancet Haematol 2024;11(12):e916–e926.
- Leen G, Stein JE, Robinson J, Torres HM, Marsh SGE. The HLA diversity of the Anthony Nolan register. HLA 2021;97(1):15–29.
- Agapiou M, Natarajan RHL, Rutt C, Misra S, Robinson J, Cereb N et al. Modeling an international donor recruitment strategy in a collaborative pilot study between a UK and Indian donor registry. HLA 2024;103:62.
- Schmidt AH, Sauter J, Baier DM, Daiss J, Keller A, Klussmeier A et al. Immunogenetics in stem cell donor registry work: The DKMS example (Part 1). Int J Immunogenet 2020;47:13–23.
- Shaw BE, Mayor NP, Szydlo RM, Bultitude WP, Anthias C, Kirkland K et al. Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants. Bone Marrow Transplant 2017;5:717–725.
- Shaw BE, Marsh SGE, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006;107(3):1220–1226.
- Al Malki MM, Bo-Subait S, Logan B, Olson J, Kou J, Smith S et al. Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation. J Clin Oncol 2025;43:2772–2781.
- Office of Health Economics. The value of cell and gene therapies to the UK economy. Available at: www.ohe.org/wp-content/uploads/2025/10/Sampson-at-al.-2025-The-value-of-cell-and-gene-therapies-to-the-UK-economy-FINAL.pdf
- Olesko KM, Eames A, Mody CCM, Lowy I, Zeller T, Walker M et al. The crisis in American science. History Sci 2025;63(2):125–165.